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Background: Previous studies have shown that the presence of left bundle branch block (LBBB)
is associated with an increased risk of cardiac mortality and heart failure (HF). Recently, new
criteria to define strict LBBB have been proposed: QRS duration ≥140 ms for men and
≥130 ms for women, along with mid-QRS notching or slurring in ≥2 contiguous leads.
Hypothesis: We assessed the prevalence and prognostic significance of LBBB according to
classical (QRS duration ≥120ms) and strict criteria in permanent pacemaker patients.
Methods: We retrospectively enrolled 723 consecutive patients who had undergone single- or
dual-chamber pacemaker implantation at the study center from July 2002 to December 2014.
Patients with a left ventricular ejection fraction ≤35% or a prior diagnosis of HF were
excluded.
Results: LBBB was reported in 54 (7%) patients, and strict-LBBB in 15 (2%) patients. During a
median follow-up of 48 months (range, 18–92 months), 147 (20%) patients reached the com-
bined endpoint of death or HF hospitalization. Patients with LBBB and those with strict-LBBB
displayed significantly higher rates of death or HF hospitalization (log-rank test, all P < 0.0001).
In particular, strict-LBBB was associated with the worst outcome. The presence of LBBB
according to classical definition criteria (hazard ratio [HR] = 1.98, confidence interval [CI]: 1.23-
3.19, P = 0.005) and to strict criteria (HR = 2.20; CI: 1.04-4.65; P = 0.039) were both confirmed
as independent predictors of death or HF hospitalization after adjustment for relevant clinical
covariates.
Conclusions: Among patients who had undergone standard pacemaker implantation, the preva-
lence of LBBB was 7% according to classical definition criteria and 2% according to strict cri-
teria. The presence of LBBB, and particularly of strict-LBBB, at the baseline predicted a poor
outcome in terms of death or HF hospitalization.
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1 | INTRODUCTION
Left bundle branch block (LBBB) is a conduction disorder that results
in intra- and inter-ventricular mechanical dyssynchrony and
consequently causes impairment of systolic and diastolic left ventric-
ular (LV) function.1 LBBB has been shown to have a negative impact
on prognosis, particularly in the context of structural heart disease,
whether of ischemic2 or non-ischemic etiology.3
In patients who receive permanent pacemakers for the treat-
ment of cardiac rhythm disturbances, right ventricular (RV) pacing
mimics an LBBB and has been shown to equally impair LV function
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by inducing dyssynchronous contraction and relaxation.4 Over long-
term follow-up, chronic RV pacing contributes to the development
of heart failure (HF) and is associated with an increased risk of mor-
bidity and even mortality.5 Moreover, even in patients with normal
LV function and an indication for permanent pacing, the presence of
a native LBBB has been shown to predict HF death or
hospitalization.6
Recently, new electrocardiographic (ECG) criteria have been pro-
posed for the diagnosis of LBBB.7 These criteria are stricter than the
current criteria8 and thus increase the specificity of LBBB diagnosis.9
However, the prognostic significance of these new criteria has not
yet been investigated in patients with indications for permanent
pacing.
The aim of this study was to assess the prevalence and prognos-
tic significance of LBBB according to classical and strict criteria in
permanent pacemaker patients.
2 | METHODS
2.1 | Patient selection, pacemaker implantation, and
follow-up
We retrospectively enrolled all consecutive adult patients in whom
pacemaker implantation had been performed from July 2002 to
December 2014 at the Santa Maria della Stella Hospital in Orvieto,
Italy. Patients were required to have standard indications for perma-
nent single- or dual-chamber pacing. Patients with evidence of sys-
tolic dysfunction (LV ejection fraction [LVEF] ≤35%) or a prior
diagnosis of HF were excluded from the analysis. The study was
approved by the local ethics committee, and informed consent was
obtained from all patients to allow data handling and access to the
medical records for research and clinical reporting purposes. Devices
and pacing leads were implanted by means of standard techniques.
Atrial leads were routinely implanted in the right atrial appendage
and ventricular leads in the right apex.
Baseline evaluation included demographics and medical history,
clinical examination, 12-lead electrocardiogram, and echocardio-
graphic evaluation of LVEF, calculated by means of Simpson’s
equation.
Optimization of pacing parameters and pharmacological treat-
ments were based on clinical evaluation by the attending physicians.
During follow-up, patients returned for regular clinic visits every
6 months. At each scheduled or unscheduled visit, the pacemaker
was interrogated and stored data were retrieved.
2.2 | 12-lead ECG
A standard ECG was recorded at the time of pacemaker implantation
in the supine position during quiet respiration, at a paper speed of
25 and 50 mm/s and at a standard gain of 1 mV/cm. For the purpose
of the study, LBBB was defined according to classical and strict defi-
nitions. Classical LBBB was defined according to the American Heart
Association/American College of Cardiology Foundation/Heart
Rhythm Society recommendations8: native QRS duration ≥120 ms;
broad (frequently notched or slurred) R waves in leads I, aVL, V5, or
V6; absent q waves in leads I, V5, and V6; R peak time >60 ms in
leads V5 and V6 but normal in leads V1, V2, and V3, when small ini-
tial r waves can be discerned in the above leads. Strict-LBBB was
defined according to the criteria proposed by Strauss et al.7: QRS
duration ≥140 ms for men and ≥130 ms for women, QS or rS in V1–
V2, mid-QRS notching or slurring in at least 2 contiguous leads (V1,
V2, V5, V6, I, and aVL). In patients requiring continuous ventricular
pacing, intrinsic conduction was sought by slowing down the pacing
rate. In the case of pacemaker dependency, patients were excluded
from the QRS analysis. Pacemaker dependency was defined as the
absence of intrinsic conduction for at least 30 seconds after gradual
slowing down of the pacing rate to 30 beats/minute.10 The ECGs
were reviewed by an observer blinded to the patients’ clinical course
and outcome.
2.3 | Clinical events and patient outcome
In the present analysis, we measured the combined endpoint of death
and HF hospitalization. The diagnosis of HF was based on the pre-
senting symptoms, clinical findings, and appropriate investigations, in
accordance with the guidelines for the diagnosis and treatment of
acute and chronic HF.11 Mortality data were obtained by means of
hospital file review or direct telephone contact, and hospitalizations
were collected from medical records.
2.4 | Statistical analysis
Continuous data were expressed as mean  standard deviation. Cat-
egorical data were expressed as percentages. Event rates were sum-
marized by constructing Kaplan-Meier curves. The log-rank test was
applied to evaluate differences between trends (level of significance
adjusted for multiple testing by Bonferroni correction). Cox regres-
sion was used to analyze possible predictors of death and HF hospi-
talization. All variables associated to a P value <0.05 on univariate
analysis were entered into the multivariate regression analysis. A
P value <0.05 was considered significant for all tests. All statistical
analyses were performed by means of STATISTICA software, version
7.1 (StatSoft, Inc., Tulsa, OK).
3 | RESULTS
3.1 | Study population and baseline evaluation
From July 2002 to December 2014, a total of 723 consecutive
patients with a standard indication for permanent single- or dual-
chamber pacing underwent pacemaker implantation in our center.
Patients included in the present analysis had no history of HF and
had an LVEF >35%. Table 1 shows baseline clinical variables and the
indications for pacemaker implantation. The baseline 12-lead ECG
revealed an LBBB in 54 (7%) patients, and a strict-LBBB in 15 (2%)
patients; the absence of intrinsic rhythm was recorded in
122 patients.
378 MAZZA ET AL.
3.2 | Follow-up
During a mean follow-up of 48 months (range, 18-92 months),
147 (20%) patients reached the combined endpoint of death or HF
hospitalization. In detail, 100 (14%) patients died, 47 (7%) were hospi-
talized for HF, and 26 (4%) experienced both events. All-cause death
was reported in 87 patients without LBBB, 6 patients with strict-
LBBB, and 7 patients with LBBB but no-strict-LBBB. The Figure 1
shows the Kaplan-Meier survival curves regarding death or HF hospi-
talization, stratified by the presence or absence of LBBB according to
classical and strict definitions (no-LBBB = 0; LBBB and no-strict-
LBBB = 1; strict-LBBB = 2). Patients with LBBB or strict-LBBB dis-
played significantly higher rates of death or HF hospitalization
(14 and 8 combined events, respectively) than those without LBBB
(125 combined events) (log-rank test, all P < 0.0001), strict-LBBB
being associated with the worst outcome.
At the time of the last follow-up visit, the mean cumulative ven-
tricular pacing percentage was 59%  39%. The percentage pacing
was 59%  39% in the no-LBBB group and 55%  36% in the LBBB
group (P = 0.371). In the 2 groups, the number of patients who
received ≥80% of pacing was 297 (44%) and 18 (33%), respectively
(P = 0.115).
Baseline parameters and ventricular pacing percentage were
evaluated by means of univariate and multivariate analyses to assess
their ability to predict the occurrence of death or HF hospitalization
during follow-up, as reported in Table 2. On univariate analysis, the
factors that showed a significant association with the combined end-
point were: older age, presence of LBBB according to either defini-
tion, diabetes, chronic obstructive pulmonary disease, chronic kidney
disease, LVEF <50%, and the percentage of ventricular pacing. There-
fore, the presence of LBBB according to classical definition criteria
and to strict criteria were separately tested by multivariate analysis.
In model 1, the LBBB according to the classical definition was con-
firmed as an independent predictor of death or HF hospitalization
(hazard ratio [HR] = 1.98, confidence interval [CI]: 1.23-3.19,
P = 0.005). Similarly, the strict-LBBB, included in model 2, was inde-
pendently associated with the endpoint (HR = 2.20, CI: 1.04-4.65,
P = 0.039). Additional variables confirmed as independent predictors
of death or HF hospitalization in both models were older age, chronic
kidney disease, and LVEF <50%.
4 | DISCUSSION
In the present study we demonstrated that in patients who had
undergone standard pacemaker implantation the prevalence of native
LBBB was 7% according to classical definition criteria and 2% accord-
ing to strict criteria. The presence of LBBB, and in particular of strict-
TABLE 1 Demographics, baseline clinical parameters, and indications for pacing
Parameter All Patients, N = 723 no-LBBB, N = 669 LBBB, N = 54 P
Male gender, n (%) 413 (57) 386 (58) 27 (50) 0.272
Age, y 77  9 77  9 79  8 0.186
Left bundle branch block
Classical definition, n (%) 54 (7) 0 (0) 54 (100) —
Strict definition, n (%) 15 (2) 0 (0) 15 (28) —
Atrial fibrillation, n (%) 196 (27) 190 (28) 6 (11) 0.006
Coronary artery disease, n (%) 119 (16) 113 (17) 6 (11) 0.271
Hypertension, n (%) 538 (74) 499 (75) 39 (72) 0.701
Diabetes mellitus, n (%) 158 (22) 143 (21) 15 (28) 0.273
COPD, n (%) 135 (19) 127 (19) 8 (15) 0.450
Chronic kidney disease, n (%) 107 (15) 94 (14) 13 (24) 0.046
LV ejection fraction <50%, n (%) 94 (13) 78 (12) 16 (30) <0.001
Clinical indication for pacing
Sick sinus syndrome 317 (44) 304 (45) 13 (24) 0.002
Atrioventricular block 229 (31) 210 (31) 19 (35) 0.564
AF with slow ventricular response 127 (18) 112 (17) 15 (28) 0.040
Carotid sinus syndrome 44 (6) 37 (6) 7 (13) 0.028
Vasovagal syncope 6 (1) 6 (1) 0 (0) 1.000
Pacing mode
AAI 4 (1) 4 (1) 0 (0) 1.000
DDD 459 (63) 428 (64) 31 (57) 0.335
DDDR 108 (15) 105 (16) 3 (6) 0.046
VDD 7 (1) 6 (1) 1 (2) 0.421
VVI 102 (14) 88 (13) 14 (26) 0.010
VVIR 43 (6) 38 (6) 5 (9) 0.285
Cumulative ventricular pacing percentage, % 59  39 59  39 55  36 0.371
Abbreviations: AF, atrial fibrillation; COPD, chronic obstructive pulmonary disease; LBBB, left bundle branch block; LV, left ventricular.
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LBBB, at the baseline predicted a poor outcome in terms of death or
HF hospitalization.
Conduction disorders have been shown to have a negative
impact on prognosis. Right bundle branch block is associated with an
increased risk of mortality in general population and patients with
heart disease.12 LBBB is associated with new-onset HF over long-
term follow-up in the general population and in the presence of
impaired LV systolic function of ischemic etiology.13 LBBB is also an
established risk factor for HF progression in patients with cardiac dis-
ease.14 In the long term, isolated LBBB has been associated with an
increase in cardiac mortality and HF progression.15
However, the ECG criteria adopted to accurately define LBBB
are debated. A prolonged QRS complex may reflect a block within
the right bundle branch or an intraventricular conduction delay
caused by delays primarily in the ventricular myocardium (ie, left ven-
tricular dilation or hypertrophy). By contrast, in the presence of
LBBB, there is a significant delay between activation of the interven-
tricular septum and activation of the LV free wall. Endocardial map-
ping studies have shown that approximately one-third of patients
diagnosed as having a complete LBBB may actually have delayed
conduction throughout the LV because of underlying hypertrophy or
left anterior fascicular block.7,9,16
Recently, Strauss et al7 proposed stricter diagnostic criteria for
LBBB, including longer QRS duration (≥140 ms in men, ≥130 ms in
women) and the presence of mid-QRS notching/slurring in more than
2 contiguous leads. These criteria derive from electrical mapping and
echocardiographic studies in humans,7 and should allow to identify
the characteristic inverted activation of septum.
The importance of identifying LBBB has been emphasized in the
perspective of cardiac resynchronization therapy (CRT) for patients
with severe systolic dysfunction. Prespecified subgroup analyses of
data collected in large CRT trials17 have suggested that, in terms of
morbidity/mortality, patients with complete LBBB benefit more from
CRT than patients with nonspecific intraventricular conduction delay
or right bundle branch block. On the basis of this evidence, current
class I recommendations are restricted to patients with complete
LBBB.18
Despite ECG similarities, recent studies have demonstrated that
LBBB is associated with different LV dyssynchrony patterns from
those observed in patients on right apical pacing, both when the most
delayed activated region of the LV is considered, and when the acti-
vation pattern is taken into account.19
Chronic RV pacing was shown to worsen HF in patients with
preexisting systolic dysfunction enrolled in defibrillator trials. The
TABLE 2 Univariate and multivariate analyses of factors predicting heart failure hospitalization and death in the study population
Univariate Analysis Multivariate Analysis (1) Multivariate Analysis (2)
HR 95% CI P HR 95% CI P HR 95% CI P
Male gender 1.14 0.82-1.58 0.451 — — — — — —
Age 1.07 1.05-1.10 <0.001 1.08 1.05-1.10 <0.001 1.08 1.05-1.10 <0.001
LBBB, classical definition 3.00 1.91-4.71 <0.001 1.98 1.23-3.19 0.005 — — —
LBBB, strict definition 4.63 2.27-9.43 <0.001 — — — 2.20 1.04-4.65 0.039
Hypertension 0.99 0.69-1.41 0.948 — — — — — —
Diabetes mellitus 1.64 1.16-2.34 0.006 1.39 0.97-2.00 0.078 1.43 0.99-2.05 0.056
COPD 2.18 1.56-3.06 <0.001 1.43 0.98-2.07 0.063 1.43 0.99-2.08 0.057
Chronic kidney disease 3.05 2.15-4.34 <0.001 1.87 1.25-2.80 0.002 1.95 1.31-2.90 0.001
LV ejection fraction <50% 4.50 3.21-6.32 <0.001 2.85 1.96-4.13 <0.001 2.84 1.95-4.13 <0.001
% of ventricular pacing 1.62 1.03-2.56 0.039 1.17 0.72-1.89 0.526 1.13 0.70-1.83 0.610
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; HR, hazard ratio; LBBB, left bundle branch block; LV, left
ventricular.
FIGURE 1 Kaplan-Meier estimates of time
to HF hospitalization or death, stratified by
presence or absence of LBBB according to
classical and strict definitions (no-
LBBB = 0; LBBB & no-strict-LBBB = 1;
strict-LBBB = 2). Abbreviations: HF, heart
failure; LBBB, left bundle branch block.
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adverse response to pacing was fast and resulted in HF events after
1 year.20 By contrast, in previous trials of pacemaker therapy,21,22 the
time to the first HF event attributed to RV apical pacing was between
3 and 5 years. Similarly, our patients with a low-risk substrate (normal
LVEF, no history of HF or myocardial infarction) tolerated ventricular
desynchronization due to RV apical pacing and had a correspondingly
relatively low risk of new-onset HF. In agreement with previous stud-
ies on patients with normal LV function,5 on multivariate analysis we
did not find an association between ventricular pacing percentage
and HF events, which were predicted only by native LBBB, LVEF
<50%, and chronic kidney disease. Similar results were also reported
in the DANPACE (Danish Multicentre Randomized Trial on Single-
Lead Atrial (AAIR) Pacing versus Dual-Chamber (DDDR) Pacing in
Sick Sinus Syndrome) trial,22 in which no association was found
between the development of HF and the pacing mode or ventricular
pacing percentage.
In our population, patients with normal baseline conduction and
those with LBBB had a similar electrical activation during pacing that
moved from the RV to the LV resulting in electrical dyssynchrony.
The reason for the observed divergence in outcomes is difficult to
ascertain. However, 2 factors may play a role. First, in this study pop-
ulation the cumulative ventricular pacing percentage was about 60%,
and perhaps the dyssynchronous activation in the natively conducted
beats in the LBBB patients contributes to the difference in outcomes.
Second, as previously shown in patients with systolic dysfunction,
intrinsic LBBB and RV pacing may have an additive effect and induce
greater mechanical dyssynchrony and further impair LV function.23
In the present analysis, the association between the development
of HF during follow-up and the presence of native LBBB, especially
when it is defined according to strict criteria, matches with recent
evidence of the greater benefit of CRT in patients with LBBB defined
according to the criteria proposed by Strauss et al.7 These findings
seem to suggest that, in the presence of an accurately diagnosed
LBBB, CRT could be considered as a therapeutic option for patients
with indications for pacemaker implantation, especially in the pres-
ence of moderate LV dysfunction (LVEF <50%).
The BLOCK HF (Biventricular versus Right Ventricular Pacing in
Heart Failure Patients with Atrioventricular Block) trial investigated
the effect of CRT in patients with pacemaker indications and LVEF
<50%.24 The absolute reduction in the risk of death or hospitalization
due to HF was 4.8% over a mean follow-up of 37 months in patients
treated with CRT vs apical pacing. The expected benefits of CRT
were therefore limited in the overall population considered in the
trial, especially in light of the anticipated higher risk of complications
in patients with CRT devices. However, according to our results, in
the presence of LBBB and, in particular strict-LBBB, the implantation
of a CRT system could be appropriate to reduce the risk of HF pro-
gression. The current class of recommendation for de novo CRT
implantation in HF patients with reduced EF and an expected high
percentage of ventricular pacing is IIa.18 By contrast, only a class I
indication is provided for upgrade from conventional pacemaker ther-
apy to CRT in patients with LVEF <35% in New York Heart Associa-
tion functional class III–IV. In light of the well-known higher rate of
complications in device upgrade procedures,25 and the economic
implications of premature device replacement,26 the early
implantation of a CRT system seems justified in patients with LBBB.
In our event-free survival analysis, the curves diverged early, with
about 50% of strict-LBBB patients experiencing HF events within
2 years of pacemaker implantation.
4.1 | Limitations
The main limitation of the present study is the retrospective design
of the analysis. Some variability in the selection or management of
patients during the inclusion period may have influenced the results.
However, the study was carried out in a single center; the operators
in charge of patient selection, device implantation, and clinical man-
agement did not change during the study period; and all the patients
included were consecutive. Moreover, the evaluation of changes in
ECG or systematic echocardiographic assessments of LV function
during follow-up would have enhanced the validity of the present
findings. In addition, due to the retrospective design of the study,
accurate adjudication of the mode of death was not possible, and
only all-cause death was considered as a component of the combined
study endpoint of death and HF hospitalization.
5 | CONCLUSION
In patients with standard pacemaker indications, the prevalence of
native LBBB was 7% according to classical definition criteria and 2%
according to strict criteria. The presence of LBBB, and in particular of
strict-LBBB, at the baseline predicted a poor outcome in terms of
death or HF hospitalization. In these patients, the implantation of a
de novo CRT system could help to prevent HF. However, prospective
studies are required to demonstrate this.
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